Evaluation between 3.0 T vs 1.5 T MRI in Detection of Brain Metastasis using Double Dose Gd-DTPA
2
조회
0
다운로드
0
인용
0
참고문헌
초록
목적: 작은 뇌전이 종양의 조기 발견은 중요하다. 이 연구의 목적은 1.5 T MRI와 3.0 T MRI 간의 크기에 따른 뇌전이 종양의 발견율을 비교하는 것이다. 대상 및 방법: 폐암으로 진단 받은 162명의 환자를 대상으로 TNM 병기를 위해 뇌 MRI를 시행하였다. Gd-DTPA를 2배 용량으로 투여 후, 3.0 T MRI에서 훼손경사회복획득으로 촬영하였으며 그 후 1.5 T MRI에서 T1 스핀 에코로 촬영하였다. 3명의 방사선과 전문의가 합의하여 MRI를 판독하였으며 정성 평가를 시행하였다. 3.0 T와 1.5 T MRI에서 크기에 따라 민감도, 양성 예측률, 정확도를 평가하였다. 신호 강도를 사용하여 전이 종양과 인접 조직간의 신호강도 비를 계산하였다. 결과: 162명의 환자 중 31명에서 1.5 T 또는 3.0 T MR에 뇌전이 종양이 발견되었다. 3.0 T MRI에서 143개의 종양이 발견되었으나 1.5 T MRI에서 137개의 종양이 발견되었다. 6개의 종양이 3.0 T MRI에서만 발견되었으며 크기는 모두 3 mm 미만이었다. 3.0 T MRI의 민감도, 양성 예측률, 정확도는 각각 100%, 100%, 100%이며, 1.5 T MRI에서는 각각 95.8%, 88.3%, 85.1% 이다. SI ratio는 1.5 T MRI보다 3.0 T MRI에서 유의하게 높았다 (p=0.025). 결론: Double dose Gd-DTPA를 이용한 3.0 T MRI는 3 mm미만의 뇌전이 종양을 발견하는데 있어서 1.5 T MRI 보다 우수하다.
Abstract
Purpose : Early detection of small brain metastases is important. The purpose of this study was to compare the detectability of brain metastases according to the size between 1.5 T and 3.0 T MRI. Materials and Methods : We reviewed 162 patients with primary lung cancer who were examined for TNM staging. After administration of double dose of Gd-DTPA, MR imaging was performed with SPGR by 3.0 T MRI and then with T1 SE sequence by 1.5 T MRI. In each patient, three readers performed qualitative assessment. Sensitivity, positive predictive value, and diagnostic accuracy were calculated in 3.0 T and 1.5 T MRI according to size. Using the signal intensity (SI) measurements between the metastatic nodules and adjacent tissue, nodule-to-adjacent tissue SI ratio was calculated. Results : Thirty-one of 162 patients had apparent metastatic nodules in the brain at either 1.5 T or 3.0 T MR imaging. 143 nodules were detected in 3.0 T MRI, whereas 137 nodules were detected at 1.5 T MRI. Six nodules, only detected in 3.0 T MRI, were smaller than 3.0 mm in dimension. Sensitivity, positive predictive value, and diagnostic accuracy in 3.0 T MRI were 100 %, 100 %, and 100 % respectively, and in 1.5 T MRI were 95.8 %, 88.3 %, and 85.1 % respectively. SI ratio was significantly higher in the 3.0 T MRI than 1.5 T MRI (p=0.025). Conclusion : True positive rate of 3.0 T MRI with Gd-DTPA was superior to 1.5 T MRI with Gd-DTPA in detection of metastatic nodules smaller than 3.0 mm.
참고문헌 (22)
- "Brain metastases", 21, pp.1~23 (2003)
- "Effectof contrast dose and field strength in the magnetic resonancedetection of brain metastases", 38, pp.415~422 (2003)
- "Comparison of singleandtriple-dose contrast material in the MR screening of brainmetastases", 19, pp.821~828 (1998)
- "High-dose Gadoteridolin MR imaging of intracranial neoplasm", 2, pp.9~18 (1992)
- "Experience with high-dose gadolinium MRimaging in the evaluation of brain metastases", 13, pp.335~345 (1992)
- "Enhancement of cerebral diseases: How much contrastagent is enough? Comparison of 0.1, 0.2, and 0.3 mmol", kgGadoteridol at 0.2 T with 0.1 mmol, pp.2001, 36[DOI]
- "The effect of contrast dose,imaging time,andlesion size in the MR detection of intracerebral metastasis", 16, pp.373~380 (1998)
- "Gd-enhancedMR imaging of brain metastases:contrast as a function ofdose and lesion size", 15, pp.535~541 (1997)
- "MR evaluation ofCNS tumors:dose comparison study with gadopentetatedimeglumine and gadoteridol", 180, pp.485~491 (1991)
- "Increaseddetection of intracranial metastases with intravenous Gd-DTPA", 165, pp.619~624 (1987)
- "Brain lesioncontrast in MR imaging:dependence of field strength andconcentration of gadodiamide injection in patients andphantoms", 38, pp.14~18 (1977)
- "A review of contrast media research in 1999 -2000", 36, pp.123~130 (2001)
- "Indication related dosing formagnetic resonance contrast media", 7(5) (1977)
- "Field strength and dose dependence ofcontrast enhancement by Gadolinium-based MR contrastagents", 9, pp.998~1004 (1999)
- "Time-dependent changes in image contrast in brain tumorsafter gadolinium-DTPA", 7, pp.1013~1020 (1986)
- "Contrast enhancement of brain tumors at different MR fieldstrengths comparison of 0", pp.5 0 1413~1419
- "Magnetic resonance imaging contrast enhancement of braintumors at 3 tesla versus 1.5 tesla", 37, pp.114~119 (2002)
- "Surgical treatment ofsingle brain metastasis:evaluation of results by computerizedtomography scanning", 53, pp.63~67 (1980)
- "Gd-DTPA:A review of clinical indications in central nervoussystem magnetic resonance imaging", 9, pp.929~958 (1989)
- "Suspected non-smallcell lung cancer:Incidence of occult brain and skeletalmetastases and effectiveness of imaging for detection-Pilotstudy", 211, pp.137~145 (1999)
- "Surgicalmanagement of cerebral metastases from non-small cell lungcancer", 89, pp.292~297 (2003)
- "Management of brainmetastases", 249, pp.1357~1369 (2002)
